SAGE THERAPEUTICS INC shareholders Q2 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
HARBOR CAPITAL ADVISORS, INC. 21,053$989,9120.20%
EASTERLY INVESTMENT PARTNERS LLC 42,800$2,012,4560.18%
Inspire Advisors, LLC 19,553$919,3810.18%
Cavalier Investments, LLC 9,679$455,1070.17%
Virtus ETF Advisers LLC 5,920$278,3580.16%
PLATINUM INVESTMENT MANAGEMENT LTD 91,933$4,322,6900.15%
PAX Financial Group, LLC 14,131$664,4400.15%
PINNACLE ASSOCIATES LTD 181,988$8,557,0760.15%
ESSEX INVESTMENT MANAGEMENT CO LLC 20,360$957,3270.13%
LORD, ABBETT & CO. LLC 827,577$38,9130.13%
FOX RUN MANAGEMENT, L.L.C. 9,606$451,6740.13%
Edgestream Partners, L.P. 27,349$1,285,9500.12%
HUSSMAN STRATEGIC ADVISORS, INC. 12,400$583,0480.11%
Empowered Funds, LLC 57,153$2,687,3340.09%
EA Series Trust 57,153$2,687,3340.09%
TWINBEECH CAPITAL LP 95,417$4,486,5070.09%
Verition Fund Management LLC 139,105$6,540,7170.09%
Ergoteles LLC 35,309$1,660,2290.08%
Inspire Investing, LLC 13,880$652,6220.08%
Candriam S.C.A. 227,000$10,673,5400.08%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q2 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.